Ispecimen Inc. (ISPC)
NASDAQ · Healthcare
Ispecimen Inc. Operating Income 2020–2025
Ispecimen Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Ispecimen Inc. operating income for the quarter ending March 31, 2026 was -2.5 M, a 54.93% increase year-over-year.
- Ispecimen Inc. operating income for the twelve months ending March 31, 2026 was -8.8 M, a 2.79% decrease year-over-year.
- Ispecimen Inc. annual operating income for 2025 was -9.0 M, a 29.46% decrease from 2024.
- Ispecimen Inc. annual operating income for 2024 was -12.7 M, a 13.96% increase from 2023.
- Ispecimen Inc. annual operating income for 2023 was -11.2 M, a 9.65% increase from 2022.
- Ispecimen Inc. annual operating income for 2022 was -10.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ispecimen Inc. Operating Income — FAQ
Ispecimen Inc. (ISPC) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Ispecimen Inc.'s operating income?
Ispecimen Inc. (ISPC) reported operating income of -$9M for fiscal 2025.
Where can I see ISPC's operating income history?
The chart and table above show Ispecimen Inc.'s operating income by year and by quarter, including the growth rate.